Characteristics Pre ART No (%) HAART No (%) Total No (%)
Functional Status B     
Working             
Ambulatory & Bedridden

223 (96.1)
9 (3.9)

213 (91.8)
19 (8.2)

436 (94)
28 (6)
WHO Stage B           
Stage I
Stage II
Stage III
Stage IV

181 (78)
42 (18.1)
9 (3.9)
0 (0)

134 (57.8)
32 (13.8)
56 (24.1)
10 (4.3)

315 (67.9)
74 (16)
65 (14)
10 (2.1)
Hemoglobin level B  
<10mg/dl
≥10mg/dl

12 (5.2)
220 (94.8)

24 (10.3)
208 (89.7)

36 (7.8)
428 (92.2)
CD4+ Count B               
<200
200-349
350-499
>=500

0 (0)
14 (6)
93 (40)
125 (54)

107 (46.1)
116 (50)
8 (3.5)
1 (0.4)

107 (23)
130 (28)
101 (21.8)
126 (27.2)
Substance use B
Yes
No

24 (10.3)
208 (89.7)

58 (25)
174 (75)

82 (17.7)
382 (82.3)
Prophylaxis B
Yes
No

62 (26.7)
170 (73.3)

206 (88.8)
26 (11.2)

268 (57.8)
196 (42.2)
CD4+ Count F               
<200
200-349
350-499
>=500

20 (8.6)
62 (26.7)
68 (29.3)
82 (35.4)

13 (5.6)
71 (30.6)
76 (32.8)
72 (31)

33 (7.1)
133 (28.7)
144 (31)
154 (33.2)
Substance use F
Yes
No

25 (10.8)
207 (89.2)

55 (23.7)
177 (76.3)

70 (17.2)
384 (82.8)
Prophylaxis F
Yes
No

95 (40.9)
137 (59.1)

98 (42.2)
134 (57.8)

193 (41.6)
271 (58.4)
Functional Status F    
Working             
Ambulatory & Bedridden

186 (90.2)
46 (19.8)

230 (99.1)
2 (0.9)

466 (89.7)
48 (10.3)
F =follow up, B= baseline
Table 2: Baseline and follow up characteristics of HIV infected patients in public Health facilities of Arba Minch town, 2014.